Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab, CAPOX, and Radiotherapy for MSS Locally Advanced Rectal Cancer
NCT06204094Phase 2Recruiting
- Sponsor
- Jinhua Hospital of Zhejiang University
- Start
- Feb 2024
- Primary completion
- Sep 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in rectal cancer, sponsored by Jinhua Hospital of Zhejiang University. Started Feb 2024; status: recruiting.
02
Drugs
sintilimab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT06204094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06204094.